Arthritis & Rheumatic Diseases

A new review by the European Reference Network for Rare Connective Tissue Diseases aims to raise awareness of IgG4-related disease among primary care clinicians.

Could an allogenic approach replace CAR T cell therapy? ACR Convergence 2024 coverage.

Expect more treatment options as new understandings about SLE’s pathogenesis emerge.

From FMLA loopholes to mutation seekers, rare disease researchers and strategists describe their game-changing work at NORD’s Breakthrough Summit 2024.

From improving trials to tackling care deserts, the conference’s oral poster presenters have a plan to move medicine forward.

A review of current and emerging therapeutics – and how they work.

Results of a large, registry-based study may guide prevention efforts in arthritis, osteoporosis, and more.

With no diagnostic biomarkers for immunoglobulin G4-RD, diagnosis is a challenge. A case scenario demonstrates how to assess for clinical, serologic, radiologic, and histopathologic features.